These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31502309)

  • 1. Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab.
    Honma M; Nozaki H; Hayashi K; Iinuma S; Ishida-Yamamoto A
    J Dermatol; 2019 Dec; 46(12):e468-e469. PubMed ID: 31502309
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
    Nishida M; Takeichi T; Kono M; Imanishi A; Maekawa N; Akiyama M; Fukai K
    J Dermatol; 2020 Mar; 47(3):e77-e78. PubMed ID: 31907962
    [No Abstract]   [Full Text] [Related]  

  • 3. Generalization of palmoplantar pustulosis after withdrawal of etretinate.
    Miyagawa S; Muramatsu T; Shirai T
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):305-6. PubMed ID: 2007689
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients.
    Xiaoling Y; Dan S; Hongzhong J
    An Bras Dermatol; 2019; 94(6):658-663. PubMed ID: 31789248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Infiltration of Pathogenic Migratory and Resident T Cells Is Decreased by Secukinumab Treatment in Psoriasis.
    Fujiyama T; Umayahara T; Kurihara K; Shimauchi T; Ito T; Aoshima M; Otobe E; Hashizume H; Yagi H; Tokura Y
    J Invest Dermatol; 2020 Oct; 140(10):2073-2076.e6. PubMed ID: 32199992
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis.
    Bertelsen T; Kragballe K; Johansen C; Iversen L
    Int J Dermatol; 2014 Oct; 53(10):e464-6. PubMed ID: 24962808
    [No Abstract]   [Full Text] [Related]  

  • 7. Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.
    Sauder MB; Glassman SJ
    Int J Dermatol; 2013 May; 52(5):624-8. PubMed ID: 23489057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
    Reolid A; Armesto S; Sahuquillo-Torralba A; Torres T; Feltes R; Vilarrasa E; Belinchón I; Cueva P; Rodríguez L; Romero-Maté A; Vidal D; Coto-Segura P; Herrera-Acosta E; Riera-Monroig J; Salgado L; Llamas-Velasco M; Daudén E
    J Am Acad Dermatol; 2022 Sep; 87(3):705-709. PubMed ID: 35640798
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophil and monocyte chemotaxis in pustulosis palmo-plantaris and pustular psoriasis.
    Ternowitz T; Thestrup-Pedersen K
    Br J Dermatol; 1985 Nov; 113(5):507-13. PubMed ID: 4063189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis.
    Plachouri KM; Chourdakis V; Georgiou S
    Drugs Today (Barc); 2019 Sep; 55(9):587-593. PubMed ID: 31584575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.
    Li J; Wang S; Li XD; Han Y
    J Int Med Res; 2024 Apr; 52(4):3000605241247702. PubMed ID: 38661102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran-associated Acute Generalized Exanthematous Pustulosis (AGEP) in a psoriatic patient undergoing Ixekizumab and its pathogenetic mechanism.
    Schrom K; Pacifico A; Conic RRZ; Pigatto PDM; Malagoli P; Morrone A; Finelli R; Bragazzi NL; Damiani G
    Dermatol Ther; 2019 Sep; 32(5):e13018. PubMed ID: 31286621
    [No Abstract]   [Full Text] [Related]  

  • 13. Recalcitrant pustular eruptions of the extremities.
    Thormann J; Heilesen B
    J Cutan Pathol; 1975; 2(1):19-24. PubMed ID: 1225934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pustulosis palmaris et plantaris treated with methotrexate.
    Thomsen K
    Acta Derm Venereol; 1971; 51(5):397-400. PubMed ID: 4109281
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
    Gottlieb A; Sullivan J; van Doorn M; Kubanov A; You R; Parneix A; Hugot S; Milutinovic M
    J Am Acad Dermatol; 2017 Jan; 76(1):70-80. PubMed ID: 27707593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous acral eruption related to secukinumab.
    Blackcloud P; Dupuy E; Kang Y; Smart C; Hsiao J
    Dermatol Online J; 2019 Jun; 25(6):. PubMed ID: 31329391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with secukinumab in a patient with generalized pustular psoriasis preceded by palmoplantar lesions.
    Sawai N; Kawakami Y; Tachibana K; Nomura H; Miyake T; Yokoyama E; Hirai Y; Morizane S
    J Dermatol; 2023 Dec; 50(12):e413-e414. PubMed ID: 37577828
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab.
    Nagata M; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Sugiura K; Tada Y
    J Am Acad Dermatol; 2020 Mar; 82(3):758-761. PubMed ID: 31560979
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of palmoplantar pustulosis with ustekinumab--the importance of interfering with the IL23/Th17 pathway.
    Pinto-Almeida T; Torres T; Sanches M; Selores M
    Eur J Dermatol; 2013; 23(6):916-7. PubMed ID: 24280259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.